Atypical meningioma: progression-free survival in 161 cases treated at our institution with surgery versus surgery and radiotherapy
Authors:
- 28 October 2017
- journal article
- research article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 136 (1) , 147-154
Abstract
Although atypical meningioma recurs frequently in spite of total resection and/or radiotherapy, no consensus on optimal adjuvant management was found. However, several retrospective studies analysed the additional effect of adjuvant radiotherapy in atypical meningioma with inconsistent results. Therefrom, the purpose of this study was to evaluate prognostic factors influencing the recurrence/progression and progression-free survival (PFS) rates of atypical meningioma, particularly focused on the role of postoperative adjuvant radiotherapy. Between February 2001 and March 2015, 161 atypical meningioma resections were performed in our Department of Neurosurgery, of which, 128 cases underwent surgical treatment alone and 33 cases underwent surgery and radiotherapy. Kaplan-Meier analysis was used to provide median point estimates and PFS rates. The Cox-regression model was used in the univariate and multivariate analysis to identify significant factors associated with treatment. The extent of resection (Simpson grade I and II) significantly influenced the risk of recurrence (hazard ratio = 1.8, CI (95%) 1.3-2.6, p-value = 0.0004). There was no significant benefit for progression-free survival after adjuvant radiotherapy (hazard ratio = 1.48, CI (95%) 0.76-2.86, p-value = 0.22). Additionally, meningioma located at the anterior and posterior fossa showed a significantly longer PFS compared to other locations (p-value = 0.03). Adjuvant postoperative radiotherapy had no significant impact on recurrence/progression rate or PFS. The extent of resection according to Simpson grade remains the most important prognostic factor associated with lower recurrence/progression rates and longer PFS in patients with atypical meningioma. The location of the tumours at the anterior or posterior fossa was an independent factor associated with improved PFS.Keywords
This publication has 36 references indexed in Scilit:
- Atypical meningiomas – A case seriesClinical Neurology and Neurosurgery, 2012
- Long-Term Outcome After Radiotherapy in Patients With Atypical and Malignant Meningiomas—Clinical Results in 85 Patients Treated in a Single Institution Leading to Optimized Guidelines for Early Radiation TherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Update on MeningiomasThe Oncologist, 2011
- Anatomic location is a risk factor for atypical and malignant meningiomasCancer, 2010
- Treatment of atypical meningiomaJournal of Clinical Neuroscience, 2010
- Mitotic Count, Brain Invasion, and Location Are Independent Predictors of Recurrence-Free Survival in Primary Atypical and Malignant Meningiomas: A Study of 86 PatientsNeurosurgery, 2010
- LONG-TERM RECURRENCE RATES OF ATYPICAL MENINGIOMAS AFTER GROSS TOTAL RESECTION WITH OR WITHOUT POSTOPERATIVE ADJUVANT RADIATIONNeurosurgery, 2009
- Hitting a moving target: evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteriaNeurosurgical Focus, 2008
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- THE RECURRENCE OF INTRACRANIAL MENINGIOMAS AFTER SURGICAL TREATMENTJournal of Neurology, Neurosurgery & Psychiatry, 1957